Material Detail

"The Texas Tech Medcast is a podcast for medical residents, medical students, practicing physicians, and others involved in medical education and high quality, patient-centered primary care." "This episode provides an overview of a new treatment for diabetes: Januvia, a DPP-4 Inhibitor newly available to treat diabetes.

Learning Objectives: the physician audience should be able to:Explain the mechanism of action for Januvia; List Januvia's side effects, impact on A1C, indications and contraindications, and renal issues and Be able to make an informed prescribing choice

Podcast Pearl: Reminder about therapies newly approved to treat diabetes, Bayetta and Januvia (Dr. Ragain)"

This will delete the comment from the database. This operation is not reversible. Are you sure you want to do it?

Thank you for reporting a broken "Go to Material" link in MERLOT to help us maintain a collection of valuable learning materials.

If you feel this material is inappropriate for the MERLOT Collection, please click SEND REPORT, and the MERLOT Team will investigate. Thank you!

You are being taken to the material on another site. This will open a new window.

Do not show me this again